Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase

(HEAL Together Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen by Jessica F Magidson, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Maryland, College Park

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) among low-income, minoritized individuals living with opioid use disorder (OUD) in Baltimore, Maryland. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this pilot trial, the investigators will evaluate the feasibility, acceptability, and fidelity of this approach (implementation outcomes) and preliminary effectiveness on methadone treatment retention at three months.

Research Team

Jessica F Magidson, PhD

Principal Investigator

Assistant Professor

Eligibility Criteria

Inclusion Criteria

Initiated methadone at the study site or demonstrated challenges with methadone adherence in the past three months (e.g., at least one indicator of a missed methadone dose)

Minimum of 18 years old

Treatment Details

Interventions

• Peer-Delivered Behavioral Activation (Behavioural Intervention)

Participant Groups

Group I: Peer-Delivered Behavioral Activation ("Peer Activate") Experimental Treatment 1 Intervention

Participants received a peer recovery specialist-delivered behavioral activation (BA) intervention ("Peer Activate") to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention.

Who Is Running the Clinical Trial?

University of Maryland, College Park

Lead Sponsor

Trials

163

Recruited

46,800+

Kathleen McCollum

University of Maryland, College Park

Chief Executive Officer since 2021

Bachelor's degree from the Wharton School of the University of Pennsylvania, Master of Health Science in Health Finance and Management from Johns Hopkins University School of Hygiene and Public Health

Dr. Jeffrey C. Baker

University of Maryland, College Park

Chief Medical Officer since 2011

MD from Harvard Medical School

University of Maryland, Baltimore

Collaborator

Trials

729

Recruited

540,000+

Dr. Mohan Suntha

University of Maryland, Baltimore

Chief Executive Officer since 2019

MD from Jefferson Medical College, MBA from Wharton School of Business, BA from Brown University

Dr. Taofeek K. Owonikoko

University of Maryland, Baltimore

Chief Medical Officer

MD, PhD

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials

886

Recruited

677,000+

Dr. Amy P. Patterson

National Center for Complementary and Integrative Health (NCCIH)

Chief Medical Officer

MD from Johns Hopkins University

Dr. Helene Langevin

National Center for Complementary and Integrative Health (NCCIH)

Chief Executive Officer since 2018

MD from McGill University